49 related articles for article (PubMed ID: 25192863)
21. Restriction endonuclease-mediated real-time digestion-PCR for somatic mutation detection.
Zhao J; Xie F; Zhong W; Wu W; Qu S; Gao S; Liu L; Zhao J; Wang M; Zhou J; Jie H; Chen W
Int J Cancer; 2013 Jun; 132(12):2858-66. PubMed ID: 23180674
[TBL] [Abstract][Full Text] [Related]
22. Rapid and accurate detection of
Jin CE; Yeom SS; Koo B; Lee TY; Lee JH; Shin Y; Lim SB
Oncotarget; 2017 Oct; 8(48):83860-83871. PubMed ID: 29137388
[TBL] [Abstract][Full Text] [Related]
23. COLD-PCR enhanced melting curve analysis improves diagnostic accuracy for KRAS mutations in colorectal carcinoma.
Pritchard CC; Akagi L; Reddy PL; Joseph L; Tait JF
BMC Clin Pathol; 2010 Nov; 10():6. PubMed ID: 21110880
[TBL] [Abstract][Full Text] [Related]
24. Potential clinical significance of plasma-based KRAS mutation analysis using the COLD-PCR/TaqMan(®) -MGB probe genotyping method.
Liu P; Liang H; Xue L; Yang C; Liu Y; Zhou K; Jiang X
Exp Ther Med; 2012 Jul; 4(1):109-112. PubMed ID: 23060932
[TBL] [Abstract][Full Text] [Related]
25. Analysis of KRAS Mutations of Exon 2 Codons 12 and 13 by SNaPshot Analysis in Comparison to Common DNA Sequencing.
Zinsky R; Bölükbas S; Bartsch H; Schirren J; Fisseler-Eckhoff A
Gastroenterol Res Pract; 2010; 2010():789363. PubMed ID: 21197450
[TBL] [Abstract][Full Text] [Related]
26. KRAS Codon 12 and 13 Mutations in Gastric Cancer in the Northeast Iran.
Ayatollahi H; Tavassoli A; Jafarian AH; Alavi A; Shakeri S; Shams SF; Sheikhi M; Motamedi Rad N; Sadeghian MH; Bahrami A
Iran J Pathol; 2018; 13(2):167-172. PubMed ID: 30697286
[TBL] [Abstract][Full Text] [Related]
27. A Sensitive PCR-Based Method for Somatic Mutations Enrichment and Screening.
Xiong Y; Tang H
Cancer Manag Res; 2021; 13():8099-8107. PubMed ID: 34737638
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic silencing of KRAS using systemically delivered siRNAs.
Pecot CV; Wu SY; Bellister S; Filant J; Rupaimoole R; Hisamatsu T; Bhattacharya R; Maharaj A; Azam S; Rodriguez-Aguayo C; Nagaraja AS; Morelli MP; Gharpure KM; Waugh TA; Gonzalez-Villasana V; Zand B; Dalton HJ; Kopetz S; Lopez-Berestein G; Ellis LM; Sood AK
Mol Cancer Ther; 2014 Dec; 13(12):2876-85. PubMed ID: 25281617
[TBL] [Abstract][Full Text] [Related]
29. KRAS mutation in adenocarcinoma of the gastrointestinal type arising from a mature cystic teratoma of the ovary.
Li Y; Zhang R; Pan D; Huang B; Weng M; Nie X
J Ovarian Res; 2014 Sep; 7():85. PubMed ID: 25297496
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of PTEN, PI3K, MTOR, and KRAS expression and their clinical and prognostic relevance to differentiated thyroid carcinoma.
Duman BB; Kara OI; Uğuz A; Ates BT
Contemp Oncol (Pozn); 2014; 18(4):234-40. PubMed ID: 25258580
[TBL] [Abstract][Full Text] [Related]
31. Changes of KRAS Exon 2 Codon 12/13 Mutation Status in Recurrent Colorectal Cancer.
Dócs O; Fazakas F; Horváth NL; Tóth L; András C; Horváth Z; Méhes G
Pathol Oncol Res; 2015 Apr; 21(2):399-404. PubMed ID: 25248721
[TBL] [Abstract][Full Text] [Related]
32. Synergistic signaling of KRAS and thyroid hormone receptor β mutants promotes undifferentiated thyroid cancer through MYC up-regulation.
Zhu X; Zhao L; Park JW; Willingham MC; Cheng SY
Neoplasia; 2014 Sep; 16(9):757-69. PubMed ID: 25246276
[TBL] [Abstract][Full Text] [Related]
33. Isothermal gene amplification coupled MALDI-TOF MS for SARS-CoV-2 detection.
Han G; Lin Q; Yi J; Lyu Q; Ma Q; Qiao L
Talanta; 2022 May; 242():123297. PubMed ID: 35151081
[TBL] [Abstract][Full Text] [Related]
34. Sensitive detection of low-abundance in-frame deletions in EGFR exon 19 using novel wild-type blockers in real-time PCR.
Ren XD; Liu DY; Guo HQ; Wang L; Zhao N; Su N; Wei K; Ren S; Qu XM; Dai XT; Huang Q
Sci Rep; 2019 Jun; 9(1):8276. PubMed ID: 31164704
[TBL] [Abstract][Full Text] [Related]
35. Improved detection of BRAF V600E using allele-specific PCR coupled with external and internal controllers.
Yang Z; Zhao N; Chen D; Wei K; Su N; Huang JF; Xu HQ; Duan GJ; Fu WL; Huang Q
Sci Rep; 2017 Oct; 7(1):13817. PubMed ID: 29061997
[TBL] [Abstract][Full Text] [Related]
36. Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.
Vendrell JA; Mau-Them FT; Béganton B; Godreuil S; Coopman P; Solassol J
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146051
[TBL] [Abstract][Full Text] [Related]
37. Sensitive detection of trace amounts of KRAS codon 12 mutations by a fast and novel one-step technique.
Xie F; Huang J; Qu S; Wu W; Jiang J; Wang H; Wang S; Liu Q; Zhang S; Xu L; Gao S; Zhang Y; Zhao J; Chen W
Clin Biochem; 2014 Nov; 47(16-17):237-42. PubMed ID: 25192863
[TBL] [Abstract][Full Text] [Related]
38. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
[TBL] [Abstract][Full Text] [Related]
40. Unlabeled-probe high-resolution melting to detect KRAS codon 12 and 13 mutations in pancreatic adenocarcinoma tissues.
Guo W; Zhang C; Wu J; Song B; Wang B; Zhou Y; Zhou J; Shen M; Zhang C; Zhang X; Guan M; Pan B
Clin Chem Lab Med; 2012 Jan; 50(6):1035-40. PubMed ID: 22706243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
